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In the past few years hip spacers have become popular in the 
treatment  of  infected  total  hip  arthroplasties  (THAs),  with 
reported infection eradication rates of > 90% (Anagnostakos 
et al. 2006). Two methods have been described for femoral 
fixation of a hip spacer. The spacer stem can be inserted into 
the femur either by a “press-fit” method, or by cementing onto 
the proximal femur (Anagnostakos et al. 2006). It is unclear 
which of these two methods provides superior fixation and 
thus acts better in the prevention of a spacer dislocation. In 
this report, we introduce a new technique for femoral fixation 
of an antibiotic-impregnated hip spacer.  
Surgical technique
In our department, we produce hip spacers by means of a two-
parted mold (Figure 1). The mold consists of polyoxymeth-
ylene (POM). A special mold is also available for acetabular 
defects (Figure 2). For clinical use, Refobacin-Palacos (0.5 g 
gentamicin/40 g cement) as bone cement has been shown to 
have elution characteristics that are better than those of other 
bone cements (Anagnostakos et al. 2006). For the spacer pros-
thesis and the acetabular component, production of 80 g and 
40  g  of  polymethylmethacrylate  (PMMA),  respectively,  is 
required. Depending on the identity of the causative pathogen 
and its sensitivity profile, we sometimes load the bone cement 
with a second antibiotic. In cases of an unidentified bacterium 
preoperatively or if the infection was revealed during an oper-
ation for presumed aseptic conditions, we routinelly use the 
combination of 1 g gentamicin/4 g vancomycin/80 g PMMA. 
Each spacer has a head diameter of 50 mm, a stem length of 
10 cm, and a total surface area of 13,300 mm2. The acetabu-
lar component has an inside/outside diameter of 53/56 mm 
and a total surface area of 4,410 mm2. When there is to be 
a combination of antibiotics, the second antibiotic is added 
manually to the Refobacin-Palacos powder. After thorough 
Figure 2. Mold for production of the acetabular component. The com-
ponent has an inside/outside diameter of 53/56 mm and a total surface 
area of 4,410 mm2.
Figure 1. Mold, consisting of polyoxymethylene (POM), for standard-
ized production of hip spacers. Each spacer has a head diameter of 50 
mm, a stem length of 10 cm, and a total surface area of 13,300 mm2. Acta Orthopaedica 2009; 80 (3): 386–388  387
mixing, the cement’s liquid monomer is added. After attaining 
a doughy state, the cement is then poured into the two halves 
of the spacer mold. The halves are then clamped together. 
After 15 min, they are opened again and the molded spacer 
is removed.
For femoral fixation of the spacer stem, we have developed 
the “glove” technique. A sterile glove is placed in the proximal 
femur, and the fingers are bound together with a vicryl suture. 
After preparing the same mixture as used for the spacer (40 
g), the doughy bone cement is now introduced into the glove 
(Figure 3). Afterwards, the intraoperatively prepared spacer is 
inserted into the cement-filled glove (Figure 4).
The entire construction is removed after a minimum of 2 
min, yielding a spacer that is a nearly exact anatomical copy 
of the proximal femoral part (Figure 5). There is no risk that 
the spacer-glove complex will get stuck in the femur, as long 
as it is removed after 2 min—before the heat of polymeriza-
tion has started.
The glove is removed from the cement mantle around the 
spacer’s stem. Following the reinsertion of the stem (Figure 
6), the remaining doughy cement is used for punctual fixa-
tion onto the femoral resection surface. After the cement has 
hardened, the spacer is reduced (Figure 7). For implantation 
of an acetabular spacer, this is normally cemented. We do not 
consider that it is necessary to use the glove technique also for 
the acetabular component because if a dislocation occurs, this 
happens on the femoral side. To our knowledge, there have 
been no reports about dislocation of an acetabular spacer and 
we have not seen any such case in our department.
Discussion
The major factors that may influence the risk of dislocation of 
a hip spacer include the spacer’s geometry and its cervicodi-
aphyseal angle, the means of production (manually shaped vs. 
standard fit), the method of fixation to the proximal femur, and 
residual bone deficits of the acetabulum—to which the shape 
or size of the spacer cannot adapt. Despite the wide use of hip 
spacers and an estimated dislocation rate of 10–20%, there is 
no consensus on the ideal femoral fixation method.
There is controversial data in the literature regarding hip 
spacer dislocations. Leunig et al. (1998) reported dislocations 
of the hip in 5 of 12 patients after implantation of a hand-made 
spacer. The authors showed that with regard to the geometry 
a relatively small spacer femoral neck/head ratio should be 
Figure 6. Reinsertion of the spacer into the femur.
Figure 5. After removal of the glove, the 
cement  mantle  around  the  stem  of  the 
spacer shows an almost exact anatomical 
copy of the proximal part of the femur.
Figure  4.  Insertion  of  the  hip  spacer  into  the 
cement-filled glove.
Figure  3.  The  antibiotic-loaded  bone 
cement, consisting of the same mixture as 
the spacer, is introduced into the glove.
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Figure 7. Articulating hip spacer fixed according to the “glove tech-
nique” in situ.
aimed for (< 0.73), and deep insertion of the spacer into the 
femur is recommended (> 57 mm). Magnan et al. (2001) and 
Duncan et al. (1993) described 1/10 and 3/13 dislocations, 
respectively, after implantation of a standardized spacer. On 
the contrary, Ries and Jergesen (1999), Koo et al.  (2001), Shin 
et al. (2002), and Takahira et al. (2003) did not observe any 
spacer dislocation in their respective series.
Despite the fact that there have been numerous reports about 
dislocations after hip spacer implantation, the precise method 
of fixation is often not well and accurately described in the 
literature. Although a proximal cementation of the spacer to 
the femur might preserve leg length and prevent any rota-
tion compared to the “press-fit” method, there have been no 
studies showing which one of the two methods is superior. 
However, one possible disadvantage of normal cementation 
of a hip spacer may be that the cement can leach through the 
pre-drilled femoral canal so that difficulties can occur at the 
spacer  explantation  later,  due  to  the  cement  removal.  The 
“glove”  technique  allows  spacer  explantation  in  one  piece 
without cement debris, thus reducing both mechanical com-
plications and operating time. Over the past 7 years, we have 
observed that the “glove” technique gives a lower dislocation 
rate than the “press-fit” method, and that it allows a shorter 
reimplantation time compared with the “normal” cementation 
because no cement debris has to be removed from the femo-
ral canal (unpublished data). Based on these observations, this 
technique has become a standard procedure in our department. 
Moreover, another advantage is that this technique can also be 
used for other, commercially available hip spacers such as the 
Spacer G or those made by using the Biomet silicon molds.
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